ANUH PHARMA LTD. - 506260 - Withdrawal Of Application For Direct Listing Of 5,01,12,000 Equity Shares.
Withdrawal of application for Direct Listing of 5,01,12,000 Equity Shares of Rs. 5.00/- each fully paid up of Anuh Pharma Limited ('the Company) on the National Stock Exchange of India ('NSE'). ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
We are submitting herewith the Transcript of Earnings Audio Conference Call held on 7th February, 2022 at 4.00 PM wherein Financial Performance for Quarter and nine months ended 31st December, 2021 was discussed. ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
We are submitting herewith the Outcome of Earnings Audio Conference Call held on February 07, 2022 at 4.00 PM wherein Financial Performance for Quarter and nine months ended December 31, 2021 was discussed. ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Investor Presentation
We are submitting herewith our Company''s revised Investor Presentation for the month of February, 2022. ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Investor Presentation
We are submitting herewith our Company''s Investor Presentation for the month of February, 2022. ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith the copy of newspaper advertisement with respect to the Unaudited Financial Results for the quarter and nine months ended December 31, 2021, published in the Financial Express and Mumbai Lakshadeep on Saturday, February 05, 2022 in compliance with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. ANUH PHARMA LTD. - 506260 - Earnings Call Invite
Please find attached herewith the details for Earnings Call Invite to join the Conference Call to be held on Monday, 7th February, 2022 at 4.00 PM to discuss the Financial Performance for quarter and nine months ended December 31, 2021. ANUH PHARMA LTD. - 506260 - Appointment of Company Secretary and Compliance Officer
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that based on the recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company at their meeting held on 4th February, 2022, approved the appointment of Mr. Bharat Gangani having Membership no. A51420 w.e.f. 04, February, 2022 as the Company Secretary and Compliance Officer of the Company and shall be designated as the Key Managerial Personnel of the Company. ANUH PHARMA LTD. - 506260 - Submission Of Unaudited Financial Results For The Quarter & Nine Months Ended December 31, 2021 Along With Limited Review Report.
Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following: 1. Unaudited Financial Results for the quarter & nine months ended December 31, 2021; and 2. Limited Review Report for the quarter ended December 31, 2021. ANUH PHARMA LTD. - 506260 - Board Meeting Outcome for Outcome Of Board Meeting Dated 4Th February, 2022
Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that the Board of Directors of the Company (the "Board") at its Meeting held today i.e. Friday, 4th February, 2022, inter-alia considered and approved the following: 1.The Un-audited Financial Results along with Limited Review Report thereon for the quarter and nine months ended December 31, 2021; 2.Appointment of Mr. Bharat Gangani as the Company Secretary & Compliance Officer and designated him as a Key Managerial Personnel of the Company w.e.f. February 04, 2022.